Skip to main content


Table 5 Overall survival of the patients grouped by LDH levels

From: Palliative primary tumor resection provides survival benefits for the patients with metastatic colorectal cancer and low circulating levels of dehydrogenase and carcinoembryonic antigen

LDH level (U/mL) Overall survival (months) P
PPTR group Non-PPTR group
≤245 22.43 (4.07–86.73) 15.63 (2.80–64.50) <0.001
246–380 19.50 (4.70–65.37) 12.23 (2.33–44.43) 0.243
>380 16.83 (2.77–73.20) 15.37 (3.23–41.33) 0.892
  1. Each value is presented as median followed by range in parentheses
  2. The overall survival was compared between PPTR and non-PPTR group, and the differences were analyzed using the log-rank test
  3. LDH lactate dehydrogenase, PPTR palliative primary tumor resection